April 10, 2018; 90 (15 Supplement) April 23, 2018
A role of GPR55 in the antiepileptic properties of cannabidiol (CBD) (P2.277)
Benjamin J. Whalley, Michael Bazelot, Evan Rosenberg, Richard Tsien
First published April 9, 2018,
Benjamin J. Whalley
1GW Research Ltd Cambridge United Kingdom
Michael Bazelot
1GW Research Ltd Cambridge United Kingdom
2Reading School of Pharmacy, University of Reading Cambridge United Kingdom
Evan Rosenberg
3Neuroscience and Physiology, NYU School of Medicine New York NY United States
Richard Tsien
3Neuroscience and Physiology, NYU School of Medicine New York NY United States
A role of GPR55 in the antiepileptic properties of cannabidiol (CBD) (P2.277)
Benjamin J. Whalley, Michael Bazelot, Evan Rosenberg, Richard Tsien
Neurology Apr 2018, 90 (15 Supplement) P2.277;
Citation Manager Formats
Make Comment
See Comments
Disputes & Debates: Rapid online correspondence
No comments have been published for this article.
NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.
- Stay timely. Submit only on articles published within the last 8 weeks.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- 200 words maximum.
- 5 references maximum. Reference 1 must be the article on which you are commenting.
- 5 authors maximum. Exception: replies can include all original authors of the article.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Advertisement
Related Articles
- No related articles found.